VACCINEX
Vaccinex has developed an antibody discovery platform that enables efficient mammalian cell-based expression for expression of large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface envelope of a mammalian virus and the cell surface membrane of the infected cell. This allows them to combine the advantages of virus panning and cell sorting into one seamless selection process. This technology enables the rapid selection of 1010 antibody combinations and thus selection of high affinity leads with varied frameworks that recognize multiple epitopes. It is based in Rochester, New York.
VACCINEX
Industry:
Biotechnology Clinical Trials Health Care
Founded:
1997-01-01
Address:
Rochester, New York, United States
Country:
United States
Website Url:
http://www.vaccinex.com
Total Employee:
11+
Status:
Active
Contact:
585-271-2700
Email Addresses:
[email protected]
Total Funding:
65.9 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 ReCAPTCHA COVID-19 ReCAPTCHA V2 Akamai Hosted ClickMeeting
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Maurice Zauderer
Maurice Zauderer investment in Post-IPO Equity - Vaccinex
Jacob Frieberg
Jacob Frieberg investment in Post-IPO Equity - Vaccinex
Albert Friedberg
Albert Friedberg investment in Post-IPO Equity - Vaccinex
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Vaccinex
Official Site Inspections
http://www.vaccinex.com Semrush global rank: 5.08 M Semrush visits lastest month: 1.62 K
- Host name: 198.46.88.224
- IP address: 198.46.88.224
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
